Neudle.com: neuroleptic

Differential
(Click to cross reference)

acetylcholine

advances in neurology

adverse drug reaction

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, treatment of

antibiotics, neurologic complications with

antibodies to voltage-gated calcium channels

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticonvulsants

anticonvulsants, blood level determination of

anticonvulsants, enzyme inducing

anticonvulsants, untoward effects of

arthrogryposis multiplex

aspartate aminotransferase

attention deficit disorder with hyperactivity

atypical

autonomic dysfunction

azidodeoxythymidine

behavior

behavior modification

behavior, combative

behavioral disorder

benzodiazepine

beta adrenergic blocker

brainstem, hemorrhage, primary

calcium antagonist, side effects of

calcium channel dysfunction

CAT scan, emission, abnormal

catatonia

catatonia, lethal

catechol-o-methyltransferase inhibitor

central core disease

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebral cortical atrophy

cerebrovascular accident

cerebrovascular accident, prevention of

chest pain

chewing, impaired

children

chloride channel dysfunction

chromosomal abnormality

chromosome 19

cingulate island sign

citalopram

Clinical Pathologic Conference(C.P.C.)

clubfoot as related to neurologic disease

confusional state, acute

congenital myopathy

congestive heart failure

creatine phosphokinase(CPK)elevated

critical care unit

cultured skin fibroblasts

delirium, work up for

delusion

dementia

dementia, clinical diagnosis

dementia, prevention of

dementia, treatment of

differential diagnosis

dilantin

dilantin, toxicity

dislocated hip, congenital

disseminated intravascular coagulation(DIC)

dopamine depleting agents

drug abuse

drug holiday

drug induced neurologic disorders

drug interactions

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dysphagia

dyspnea

dystonia

dystonia, drug induced

dystonia, face

dystonia, treatment of

dystonia, truncal

dystonic reaction, acute

dystrophin

echolalia

efficacy

electrocardiogram, abnormal

electroconvulsive therapy

electroencephalogram

electroencephalogram, abnormalities of

electromyogram

electron microscopy

emergencies, medical

emergencies, neurologic

epidemiology of neurology

ergotamine

evidence-based research

exercise

extrapyramidal

facial movement disorder

facial weakness

falling

familial

familial hemiplegic migraine

fatigue

fever

fibrinolytic agents, utilization

genetic neurologic disorders

genetic screening

Gilles de la Tourette syndrome

grunting

guanfacine

hallucination

hallucination, visual

headache, intractable

headache, severe

headache, treatment of

heatstroke

hemiballismus

heralding manifestation

hyperammonemic encephalopathy

hypokalemic periodic paralysis

hyponatremia

hyporeflexia

hypotension, systemic

hypotonia

hypotonia, infants

iatrogenic neurologic disorders

impulsivity

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

inappropriate behavior

inattention

inclusion bodies

insomnia

intellectual deterioration

interobserver agreement

iron, serum

jealousy

joint hypermobility

kyphoscoliosis, neurologic causes of

lactic acidemia

L-dopa

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

lethargy

leukocytosis

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

lithium

liver function enzymes

lorazepam

lordosis

malignant hyperpyrexia

maprotiline

marihuana

medical-legal aspects of neurology

medication withdrawal

mellaril

memantine

mental retardation

mental status, abnormal

migraine, intractable

migraine, treatment of

mimics

misdiagnosis

mitral valve prolapse

molecular genetics

mortality

movement disorder

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, post hemiplegic

movement disorder, treatment of

multiminicore disease

multiple sclerosis

muscimol

muscle atrophy, static

muscle weakness, proximal

muscular dystrophy

muscular dystrophy, Becker

mutism

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myopathy, drug-induced

neuroleptic induced catatonia

neuroleptic malignant syndrome

neuroleptic sensitivity

neuroleptic, atypical

neurologic complications

neurologic disease

neurologic disease, diagnoses of

neurologic disease, diagnoses of, clinical bedside

neurological intensive care

neuromuscular blockade

neuropathology

neuropathology, brain

neuropathy

neuropathy, peripheral

Niemann-Pick disease

nonsteroidal anti-inflammatory drug

nortriptyline

nursing home

obesity

obsessive-compulsive disorder

oculogyric crisis

olanzapine

old age, neurology of

orthostatic hypotension

paramyotonia congenita

paranoia

paraspinal muscle weakness

parietal lobe, atrophy

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, fluctuations in

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, wearing off

Parkinsonism hyperpyrexia syndrome

Parkinsonism syndrome

paroxetine

paroxysmal neurologic deficits

patient information and support

penicillamine

percussion induced muscle contraction

periodic paralysis

phenothiazine

phenothiazine, dyskinesia associated with

physostigmine

pimozide

pimozide, side effects

Pisa syndrome

placebo

poison, neurologic problems with

pontine hemorrhage

posterior cortical atrophy

postoperative neurologic complications

postural abnormality

potassium channel antibodies

potassium channel dysfunction

practice guidelines

premarin

prevention of neurologic disorders

procainamide

progesterone

prognosis

progressive neurologic disorder

propranolol

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

REM sleep behavior disorder

renal failure

renal failure, acute

repetitive questioning

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respiratory dyskinesias

respiratory failure

respiratory myoclonus

restless leg syndrome

risk-benefit assessment

risperidone

rummaging

safety

salivation, excessive

schizophrenia

scoliosis

scoliosis, neurologic association with

sedation

seizure

seizure, drug-induced

seizure, dystonic

selective serotonin reuptake inhibitors

serotonin syndrome

sertraline

serum alanine aminotransferase

sleep pathology and physiology

sneeze

sniffing

snoring

sodium channel dysfunction

sodium nitroprusside

sodium valproate

sodium valproate, intravenous

somnolence

sphingomyelin

spinocerebellar ataxia

spinocerebellar ataxia type 6

stimulation, deep brain

tardive diaphragmatic flutter

tardive dyskinesia

tardive dyskinesia, treatment of

tardive dystonia

tardive pain syndrome

tic, chronic multiple

tic, classification of

tranquilizers, neurologic complications with

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

tremor

tremor, jaw

tremor, treatment of

tricyclic antidepressant

urine osmolality, elevated

wandering

weakness

weakness, progressive

weight gain

Showing articles 150 to 171 of 171 << Previous

Drug Therapy, Psychotropic Drug Use in the Elderly (Second of Two Parts)
NEJM 308:194-199, Thompson,T.L.,et al, 1983

Toxic Neurological Reaction to Lithium/Thioridazine
Lancet 1:771, Standish-Barry,H.M.A.S.,et al, 1983

Propranolol in the Treatment of Neuroleptic-Induced Akathisia
Lancet 2:685-686, Lipinski,J.F.,et al, 1983

Tardive Dystonia:Late-onset & Persistent Dystonia Caused by Antipsychotic Drugs
Neurol 32:1335-1346, Burke,R.E.,et al, 1982

Neuroleptics & Abnormal Movements
BMJ 285:463-464, Lader,M.H., 1982

The Neuroleptic Malignant Syndrome
Arch Int Med 142:1183-1185, Smego,R.A.,et al, 1982

Treatment Of Neuroleptic Malignant Syndrome With Dantrolene
Lancet 2:49-50, Goekoop,J.G.,et al, 1982

Neuroleptic Malignant Syndrome:A Pathogenetic Role for Dopamine Receptor Blockage
Neurol 31:132-137, Henderson,V.W.,et al, 1981

Meige Syndrome (blepharospasm-oromandibular Dystonia) after Long-term Neuroleptic Therapy
Neurol 31:1555-1556, Weiner,W.J.,et al, 1981

Neuroleptic Malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease
Neurol 31:1022-1026, Burke,R.E.,et al, 1981

Neuroleptic Malignant Syndrome
Arch Neurol 37:462-463, Morris,H.H.,et al, 1980

Epileptogenic Side Effects of Psychotropic Drugs
JAMA 244:1460-1463, Itil,T.M.,et al, 1980

Tardive Dyskinesia
Editorial, BMJ 2:13131979., , 1979

Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978

Malignant Hyperthermia & Central Core Disease in a Child with Congenital Dislocating Hips
Arch Neurol 35:189, Eng,G.D.,et al, 1978

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Patients Treated with Psychotherapeutic Drugs
Arch Neurol 34:374, Matuk,F.,et al, 1977

Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976

Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976

Anticonvulsant-induced Dyskinesias:A Comparison with Dyskinesias Induced by Neuroleptics
JNNP 39:1210, Chadwick,D.,et al, 1976

Neurologic Syndrome Associated with Antipsychotic Drug Use
NEJM 289:20, 1973, 290:110974., , 1974

Pathology of Malignant Hyperpyrexia
BMJ Editorial 249, 1973, Feb., , 1973

Showing articles 150 to 171 of 171 << Previous